The 16th edition of BioAsia will be organized in the city from February 25-27, 2019 at Hyderabad International Convention Center (HICC).
Earlier in the day, the Telangana State Life Sciences Advisory Committee members Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories, Prof. Balasubramanian, Distinguished Scientist (& ‘Director of Research’ Emeritus of LVPEI), Dr. Rakesh Mishra, Director, CCMB, Dr. Ajit Rangnekar, Director General, RICH among others, met with Minister for Industries and Commerce KT Rama Rao along with Jayesh Ranjan, Principal Secretary (I&C) and Director, Life Sciences & CEO of BioAsia, Shakthi Nagappan, to apprise Minister on the plans for BioAsia 2019.
The BioAsia is an annual flagship international healthcare and technology convention of the Government of Telangana organized in partnership with Government of India. A plethora of centre and state organizations including TSIIC, Research and Innovation Circle of Hyderabad (RICH), State Innovation Cell, Federation of Asian Biotech Associations (FABA), BIRAC, Invest India, Department of Pharmaceuticals, CSIR etc will come together in organizing this prestigious event.
The Minister said “BioAsia has gained quite a high recognition over the years and has been witnessing participation of Life Sciences and Healthcare leaders from over 50 Countries every year. BioAsia has been an integral part of Hyderabad’s growth story and with the support of our Life Sciences Advisory committee; we are committed to magnifying the scale of the event to greater heights. With Hyderabad’s capabilities in both Technology and Life Sciences, we are best positioned to leverage digital synergies across the sector.”
“The event will be a window to the future of life-sciences and will deliver the ultimate platform to anticipate the next required shift in perspective, vision and innovation in the area of life-sciences. BioAsia has been and will continue be the instrument to project the State’s strength and commitments in the field. With the support of organizations like Innovation Cell, RICH, T-Hub, Startup India and others we are looking at scaling up the start-up focus at the event.”, Mr. Jayesh Ranjan said.
The conference has immensely benefited from its participant history including the likes of several Nobel Prize winners Dr’s Kurt Wuthrich, Ada Yonath, Harald zur Hausen, Barry Marshall, Martin J Evans, etc. and eminent industry leaders viz. Mr. Vas Narasimhan (CEO, Novartis); Dr. Paul Stoffels (Vice Chairman and EVP, Johnson & Johnson), Dr. Patrick Vallance (former Global President R&D, GSK), Mr. Sanat Chattopadhyay (EVP and President of Manufacturing, Merck & Co), Mr. Narayana Murthy, Co-Founder, Infosys, among others. Over the course of 15 years, the event has witnessed participation from more than 20,000 leaders representing over 93 Countries visiting Hyderabad and has conducted more than 16,000 partnering meetings. It may be worth mentioning that projects worth INR 15,000 Crores (approx.) have been announced at the previous editions of the event.
“BioAsia 2019 event will be organized with the theme of “Life Sciences 4.0 – Disrupt the Disruption” focused on re-imagining healthcare as a result of technological change and rising customer expectations, while deliberating the ramifications for life sciences companies’ market offerings, business models and the new capabilities needed as the disciplines of health care and technology merge to become Digital Medicine”, said Mr. Shakthi Nagappan, CEO, BioAsia.
The “Pricing pressures are forcing Governments / healthcare authorities to prioritize better health outcomes at reduced costs leading the Industry to shift towards data-driven, platform-based business models referred as ‘Life Sciences 4.0’. Embracing Life Sciences 4.0 is both an urgent need and a blossoming opportunity for Indian life sciences companies to explore. If Life Sciences companies can leverage platforms to combine their proprietary data with environmental, behavioral and financial insights, they can position themselves to capture maximum future value. Realizing this transformative opportunity, BioAsia 2019, is themed on Life Sciences 4.0 where the industry experts will share their thoughts on global trends and ramifications for all industry stakeholders” he said. Ernst & Young has been roped in as the exclusive Knowledge partner for the event.
The “BioAsia is a great place to connect for anyone associated with the life sciences space. It brings together the best of people and companies in their respective fields to share their ideas on contemporary research and provides an opportunity to collaborate in partnerships that can create tremendous value. 2019 convention promises to be an exciting one given the current developments in the life sciences industry, especially the pharmaceuticals sector” said Satish Reddy, Chairman, Dr. Reddy Laboratories.
BioAsia 2019 will introduce a Capital Pavilion platform allowing funding opportunities to researchers, startups, SMEs, institutions and organizations from philanthropic organizations, angel investors and venture capitalists for investing in path-breaking research and product development. The platform aims to invigorate entrepreneurship in the life sciences sector and invites much needed risk-capital towards innovative research.
More information on BioAsia 2019 is available at www.2019.bioasia.in
